Bristol Myers Squibb Drug Patent Portfolio

Bristol Myers Squibb's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Bristol Myers Squibb News

Johnson & Johnson Receives USFDA Approval for Oral Psoriasis Medication Icotyde - Medical Dialogues

19 Mar, 2026

FDA grants approval for Johnson & Johnson's oral medication for psoriasis - ET Pharma

18 Mar, 2026

FTC Increases Antitrust Scrutiny on Pharmaceutical Industry as Major Drug Patents Near Expiration

18 Mar, 2026

FDA Gives Green Light to Johnson & Johnson's Oral Medication for Psoriasis

18 Mar, 2026

See More